Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tegoprubart by Eledon Pharmaceuticals for Kidney Transplant Rejection: Likelihood of Approval
Tegoprubart is under clinical development by Eledon Pharmaceuticals and currently in Phase II for Kidney Transplant Rejection. According to GlobalData,...
Data Insights
Risk adjusted net present value: What is the current valuation of Eledon Pharmaceuticals's Tegoprubart?
Tegoprubart is a monoclonal antibody commercialized by Eledon Pharmaceuticals, with a leading Phase II program in Kidney Transplant Rejection. According...